Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Test for use on the widely available, high-throughput cobas® 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. Continue reading
In the event of an evacuation, here’s what you can do to prepare. Continue reading
Mylan said it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary Clinton criticized the drug’s high price. Bobbi Rebell reports.
One person has died and five others are in a serious condition after taking part in a French drug trial of an experimental painkiller.